Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Up-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by ß-Klotho.
Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?
Laminar cortical damage in multiple sclerosis.
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Phenytoin in acute optic neuritis: neuroprotective or not?
Exercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trial.
[An update on the treatment options for multiple sclerosis].
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
[Disruption of the blood-brain barrier in inflammatory neurological diseases].
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.
Improving Safety and Operational Efficiency in Residential Care Settings With WiFi-Based Localization.
Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica.
The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses.
Multiple sclerosis: Rapid screening for remyelination-promoting drugs using micropillar arrays.
Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies.
Hematopoietic progenitors express myelin basic protein and ensheath axons in Shiverer brain.
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A.
Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity.
The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes.
Transcriptional expression of MBP in oligodendrocytes depends on functional syntaxin 4; a potential correlation with autocrine signalling.
Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.
Pages
« first
‹ previous
…
334
335
336
337
338
339
340
341
342
…
next ›
last »